Menu Search
Equities

Boston Scientific Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
B1SX34:SAO

Boston Scientific Corp

Actions
  • Price (BRL)392.92
  • Today's Change9.95 / 2.60%
  • Shares traded7.00
  • 1 Year change-35.13%
  • Beta--
Data delayed at least 15 minutes, as of Feb 14 2026 00:45 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BSX:NYQ since
announced		Transaction
value
Penumbra IncAnnounced15 Jan 202615 Jan 2026Announced-20.28%15.05bn
Valencia Technologies CorpDeal completed12 Jan 202612 Jan 2026Deal completed-23.46%--
Nalu Medical IncAnnounced17 Oct 202517 Oct 2025Announced-23.57%533.00m
Elutia Inc-BioEnvelope BusinessDeal completed09 Sep 202509 Sep 2025Deal completed-30.90%88.00m
SoniVie LtdDeal completed03 Mar 202503 Mar 2025Deal completed-28.00%540.00m
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
BRAM - Bradesco Asset Management SA DTVMas of 30 Sep 20251.17k0.00%
XP Allocation Asset Management Ltda.as of 30 Sep 2025198.000.00%
Empiricus Gestao De Recursos Ltda.as of 30 Sep 20250.000.00%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.